Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
668
datasets available to search
ShareScore release 0.9.0
Dataset results
668 results for “Everolimus”
Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent
ClinicalTrials.gov study NCT01233453. IPD Sharing: Not stated. Countries: 4. Publications: 2.
Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients
ClinicalTrials.gov study NCT00464399. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin
ClinicalTrials.gov study NCT02695459. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus
ClinicalTrials.gov study NCT02328963. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients
ClinicalTrials.gov study NCT00170859. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy
ClinicalTrials.gov study NCT02049047. IPD Sharing: NO. Countries: 1. Publications: 1.
Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer
ClinicalTrials.gov study NCT01164176. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Rotating Pazopanib and Everolimus to Avoid Resistance
ClinicalTrials.gov study NCT01408004. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma
ClinicalTrials.gov study NCT01028638. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab
ClinicalTrials.gov study NCT02248571. IPD Sharing: NO. Countries: 1. Publications: 5.
Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator
ClinicalTrials.gov study NCT02113800. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents
ClinicalTrials.gov study NCT01711931. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.
ClinicalTrials.gov study NCT03525834. IPD Sharing: YES. Countries: 1. Publications: 0.
Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or
ClinicalTrials.gov study NCT03065387. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma
ClinicalTrials.gov study NCT01804374. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator
ClinicalTrials.gov study NCT02017860. IPD Sharing: YES. Countries: 1. Publications: 0.
A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Unde
ClinicalTrials.gov study NCT02579031. IPD Sharing: Not stated. Countries: 1. Publications: 18.
Dose EScalation Induction of EvERolimus
ClinicalTrials.gov study NCT02387099. IPD Sharing: Not stated. Countries: 1. Publications: 1.
XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study
ClinicalTrials.gov study NCT00631228. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions
ClinicalTrials.gov study NCT01186120. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.